Back to Newsroom
Back to Newsroom

Laxxon Medical to Participate in 25th Annual Needham Growth Conference

Thursday, 05 January 2023 08:00

NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth Conference at the Lotte New York Palace Hotel on January 10-12, 2023.

Helmut Kerschbaumer, CEO/Chairman, and Alexander Ruckdaeschel, Chief Strategy Officer, will hold one-on-one meetings with institutional, private equity, and venture capital investors throughout the day on January 12, 2023.

About Laxxon Medical Corporation

Laxxon Medical is a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions through SPID®-Technology (Screen Printing Innovational Drug Technology), an additive 3D screen printing technology and manufacturing process. Laxxon Medical holds the exclusive worldwide rights to the use and application of SPID®-Technology for the development, manufacture, and commercialization of pharmaceutical dosage forms.

For more information, visit or follow Laxxon Medical on LinkedIn or Twitter.

Investor Contact:

Alexander Ruckdaeschel
Chief Strategy Director
[email protected]

Media Contact:

Frances Hoggard
Communications Manager
[email protected]

SOURCE: Laxxon Medical Corporation

Back to newsroom
Back to Newsroom
Share by: